Evidence map›Paper›PMID 37415734›Full record

ArticleOncology research2023

Targeting LncRNA

L I Tian, Yongyi Huang, Baozhen Zhang, Y I Song, Lin Yang, Qianqian Chen, Zheng Wang, Yiling Wang, Qihan He, Wenhan Yang and 7 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

L I TianSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Yongyi HuangSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Baozhen ZhangShenzhen Institute of Advanced Technology, Chinese Academy of Science, Shenzhen, China.
Y I SongSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Lin YangDepartment of Thoracic Surgery, Shenzhen People's Hospital, Shenzhen, China.
Qianqian ChenSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Zheng WangDepartment of Thoracic Surgery, Shenzhen People's Hospital, Shenzhen, China.
Yiling WangSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Qihan HeSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Wenhan YangSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Shuyong YuDepartment of Gastroenterology, Hainan Tumor Hospital, Haikou, China.
Tianyu LuDepartment of Gastroenterology, Southern University of Science and Technology Hospital, Shenzhen, China.
Zichen LiuSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Kaiping GaoSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Xiujun FanShenzhen Institute of Advanced Technology, Chinese Academy of Science, Shenzhen, China.
Jian SongDepartment of Gastroenterology, Hainan Tumor Hospital, Haikou, China.
Rihong ZhaiSchool of Public Health, International Cancer Center, Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, Shenzhen, China.
Shenzhen Institutes of Advanced Technology · CNShenZhen People’s Hospital · CNSouthern University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence has indicated that long non-coding RNAs (lncRNAs) play critical roles in the development and progression of cancers, including esophageal squamous cell carcinoma (ESCC). However, the mechanisms of lncRNAs in ESCC are still incompletely understood and therapeutic attempts for

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaRNA, Long NoncodingAnimalsCell Line, TumorCell MovementCell ProliferationChromatinFemaleGene Expression Regulation, NeoplasticHumansOligonucleotides, AntisensePlacentaPregnancyChromatinOligonucleotides, AntisenseRNA, Long NoncodingAntisense oligonucleotide (ASO)ChromatinEsophageal squamous cell carcinoma (ESCC)LLNLR-299G3.1Placental chondroitin sulfate A binding peptide (plCSA-BP)-coated nanoparticles

Identifiers

PMID37415734
PMCPMC10319589
OpenAlexW4381956133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.